Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Stone Harbor Investments, Inc. | Financial_Report.xls |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 1 TO FORM 10-Q
x Quarterly Report Pursuant to Section 13 or 15(d) Securities
Exchange Act of 1934 for Quarterly Period Ended June 30, 2011
-OR-
¨ Transition Report Pursuant to Section 13 or 15(d) of the
Securities And Exchange Act of 1934 for the transaction period from
_________ to________
Commission File Number: 333-162469
LTS Nutraceuticals, Inc.
(Exact name of registrant as specified in its charter)
|
Nevada
|
27-0374885
|
|
(State or other jurisdiction
|
(I.R.S. Employer
|
|
of incorporation or organization
|
Identification Number)
|
450 East Las Olas Blvd.
Suite 830
Ft. Lauderdale, Florida 33301
(Address of principal executive offices) (zip code)
(954) 462-8895
(Registrant's telephone number, including area code)
Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ¨ No¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerate filer, or a small reporting company as defined by Rule 12b-2 of the Exchange Act):
|
Large accelerated filer ¨
|
Non-accelerated filer ¨
|
|
Accelerated filer ¨
|
Smaller reporting company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ Nox
The number of outstanding shares of the registrant's common stock, as of August 15, 2011: 42,100,000
The purpose of this Amendment is to attach the issuer’s financial statements in XBRL format. No other changes are made.
Item 6. Exhibits
EX-101 XBRL Files.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: September 13, 2011
LTS Nutraceuticals, Inc.
|
By:
|
/s/Jerry Rayman
|
|
|
Jerry Rayman, Principal Executive Officer and
|
||
|
Principal Financial and Accounting Officer
|
||